Your browser doesn't support javascript.
loading
ACR Appropriateness Criteria® Nuchal Translucency Evaluation at 11 to 14 Weeks of Gestation.
Simpson, Lynn; Maturen, Katherine E; Feldstein, Vickie A; Oliver, Edward R; Poder, Liina; Strachowski, Loretta M; Sussman, Betsy L; Weber, Therese M; Winter, Tom; Zelop, Carolyn M; Glanc, Phyllis.
Afiliación
  • Simpson L; Columbia University, New York, New York; American College of Obstetricians and Gynecologists. Electronic address: ls731@columbia.edu.
  • Maturen KE; Panel Chair, University of Michigan, Ann Arbor, Michigan.
  • Feldstein VA; University of California San Francisco, San Francisco, California.
  • Oliver ER; Children's Hospital of Philadelphia and Perelman School of Medicine at the University of Pennsylvania, Philadelphia, Pennsylvania.
  • Poder L; University of California San Francisco, San Francisco, California.
  • Strachowski LM; University of California San Francisco, San Francisco, California.
  • Sussman BL; The University of Vermont Medical Center, Burlington, Vermont.
  • Weber TM; University of Alabama at Birmingham, Birmingham, Alabama.
  • Winter T; University of Utah, Salt Lake City, Utah.
  • Zelop CM; Valley Hospital, Ridgewood, New Jersey and NYU School of Medicine, New York, New York; American College of Obstetricians and Gynecologists.
  • Glanc P; Specialty Chair, University of Toronto and Sunnybrook Health Sciences Centre, Toronto, Ontario, Canada.
J Am Coll Radiol ; 17(11S): S447-S458, 2020 Nov.
Article en En | MEDLINE | ID: mdl-33153556
A fetus with an increased nuchal translucency at 11 to 14 weeks gestation is at risk for aneuploidy, genetic syndromes, structural anomalies, and intrauterine fetal demise in both single and twin gestations. In addition to referral to genetics for counseling and consideration of diagnostic genetic testing, a detailed anatomic survey and fetal echocardiogram are indicated in the second trimester to screen for congenital malformations and major heart defects. The American College of Radiology Appropriateness Criteria are evidence-based guidelines for specific clinical conditions that are reviewed annually by a multidisciplinary expert panel. The guideline development and revision include an extensive analysis of current medical literature from peer reviewed journals and the application of well-established methodologies (RAND/UCLA Appropriateness Method and Grading of Recommendations Assessment, Development, and Evaluation or GRADE) to rate the appropriateness of imaging and treatment procedures for specific clinical scenarios. In those instances where evidence is lacking or equivocal, expert opinion may supplement the available evidence to recommend imaging or treatment.
Asunto(s)
Palabras clave
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sociedades Médicas / Medida de Translucencia Nucal Tipo de estudio: Diagnostic_studies / Guideline / Qualitative_research Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Radiol Asunto de la revista: RADIOLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos
Texto completo
Añadir a Mi BVS
Imprimir
XML
PubMed Links
Buscar en Google

Texto completo: 1 Colección: 01-internacional Base de datos: MEDLINE Asunto principal: Sociedades Médicas / Medida de Translucencia Nucal Tipo de estudio: Diagnostic_studies / Guideline / Qualitative_research Límite: Female / Humans / Pregnancy País/Región como asunto: America do norte Idioma: En Revista: J Am Coll Radiol Asunto de la revista: RADIOLOGIA Año: 2020 Tipo del documento: Article Pais de publicación: Estados Unidos